Menu

Neural Connectome Method Uses mRNA Barcodes

Researchers swap microscopy for RNA sequencing to track neural paths in the mouse brain.  

Nov 1, 2016
Ruth Williams

FOLLOW THE mRNA: To determine where in the mouse brain individual neurons have axon terminals, researchers inject a library of viral vectors in the vicinity of cell bodies. The viruses contain plasmids each encoding a unique RNA barcode and a presynaptic protein called MAPP-nλ that will shuttle the barcoded mRNA to the ends of the axon. Typically, each cell takes up only one virus, giving that cell an RNA identifier. Dissecting brain regions and sequencing the RNAs reveals which cells project where.© GEORGE RETSECK

Several ambitious brain connectome projects are underway to diagram the wiring of animals’ most complicated organ. For the most part, neural cartographers rely on microscopy, but tracing numerous projections across the large volumes of the brain is “extremely painstaking and slow,” says Thomas Mrsic-Flogel of the University of Basel.  

Inspired by recent advances in sequencing technology, Tony Zador of Cold Spring Harbor Laboratory had an idea: “If there was a way to convert the mapping problem into one of sequencing, it would be a [big] win in terms of throughput and cost.” Now, he and his colleagues have done just that.

To map neurons by sequencing, Zador’s team injects a mixture of approximately 106  viruses—each bearing a genetic sequence encoding a unique mRNA barcode—into mouse brain regions. By and large, each neuron becomes infected with one virus, and therefore receives just one barcode identifier. Two days later, once the mRNAs have travelled the lengths of the axons (guided by engineered presynaptic proteins), injection sites and target brain regions are dissected, and the RNA is extracted and sequenced. RNAs at the target sites matching those from the injection site thus represent individual neuron projections.

Zador and colleagues used the technique, called MAP-seq, to examine neuron projections into the cortex from the locus coeruleus—a site in the brainstem that is the sole source of the neurotransmitter noradrenaline for the neocortex. The team found that while some neurons branched out to multiple regions of the cortex, others connected with just one or two sites.

The experiment served as “a proof of principle,” says Zador, who now plans to perform hundreds of injections in a single mouse cortex to examine connectivity from multiple regions at once. This has the potential to “yield a hugely rich anatomical data set,” Mrsic-Flogel says. (Neuron, 91:975–87, 2016) 

MAPPING TECHNIQUE CELL LABELING TARGET SITE ANALYSIS SPATIAL RESOLUTION THROUGHPUT
Anterograde tracing One or a few cells per brain are injected with the same fluorescent label (using additional colors allows tracking of greater numbers of cells). Illuminated axon
branches are observed
with a microscope.
High. The precise locations of projections can be determined
down to the resolution limit
of the microscope.
Very low. It can take more than a week of intensive microscopy to track a single neuron’s projections.
MAP-seq Unique mRNA barcodes label individual neurons. Tissue is dissected into tiny sections. RNA is extracted and sequenced. Limited by the dissection method. Cryostat sections were 300?μm thick in this study, but laser microdissection could provide thinner pieces of tissue. High. Many thousands of individual neurons can be mapped in one week. Multiple injection sites would increase this number further.

 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.